GL1X · GenesisL1 explorer

Research workbench

Crystal structure of E. COLI hypoxanthine phosphoribosyltransferase in complexed with {[(2-[(hypoxanthin-9H-YL)METHYL]PROPANE-1,3-diyl) BIS(OXY)]BIS- (METHYLENE)}DIPHOSPHONIC acid

Analyse Crystal structure of E. COLI hypoxanthine phosphoribosyltransferase in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5KNX
Type
protein
Length
349 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hypoxanthine-guanine phosphoribosyltransferase
UniProt
A0A0U4JN50
Ligands
6WC, MG
Pockets
3 · best druggability 0.72

Structure

x-ray diffraction · 2 distinct chains · 24% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHypoxanthine-guanine phosphoribosyltransferaseprotein17324% helix, 34% strandA0A0U4JN50
BHypoxanthine-guanine phosphoribosyltransferaseprotein17624% helix, 32% strandA0A0U4JN50

Ligands and binding sites

  • 6WC · [2-[(6-oxidanylidene-1~{H}-purin-9-yl)methyl]-3-(phosphonomethoxy)propoxy]methylphosphonic acid · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14740.720.82346WC, MG
24870.700.80396WC, MG
32330.580.7920empty

Interfaces

1 interface between chains.

  • A–B · 1284 Ų buried · 15 hydrogen bonds · protein-protein

Compared structures

  • 5KNX · Crystal structure of E. coli hypoxanthine phosphoribosyltransferase in complexed with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.